Fan, Michelle

Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis

Saag, K. G., Petersen, J., Brandi, M. L., Karaplis, A. C., Lorentzon, M., Thomas, T., Maddox, J., Fan, M., Meisner, P. D., & Grauer, A. (2017) · New England Journal of Medicine

Bone health and osteoporosis researchBone health and treatments

Cited by 1,544

A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer.

Body, J.-J., Facon, T., Coleman, R. E., Lipton, A., Geurs, F., Fan, M., Holloway, D., Peterson, M. C., & Bekker, P. J. (2006) · Clinical Cancer Research

Bone health and treatmentsBone Metabolism and Diseases

Cited by 490

Randomized active-controlled phase II study of denosumab efficacy and safety in patients with breast cancer-related bone metastases.

Lipton, A., Steger, G. G., Figueroa, J., Alvarado, C., Solal-Celigny, P., Body, J.-J., de Boer, R., Berardi, R., Gascon, P., Tonkin, K. S., et al. (2007) · Journal of Clinical Oncology

Bone health and treatmentsBone health and osteoporosis research

Cited by 389

A randomized trial of denosumab (AMG 162) versus intravenous (IV) bisphosphonates (BP) in cancer patients (pts) with bone metastases (BM) on established IV BP and evidence of elevated bone resorption

Suarez, T., Fizazi, K., Rahim, Y., Wilson, J., Fan, M., Jun, S., & Lipton, A. (2006) · Journal of Clinical Oncology

Bone health and treatmentsBone health and osteoporosis research

Cited by 11